AngioDynamics (NASDAQ:ANGO) Posts Earnings Results, Beats Estimates By $0.07 EPS

AngioDynamics (NASDAQ:ANGO) posted its quarterly earnings data on Wednesday. The medical instruments supplier reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.11) by $0.07, RTT News reports. The firm had revenue of $72.90 million for the quarter, compared to analysts’ expectations of $70.93 million. AngioDynamics had a negative net margin of 83.95% and a negative return on equity of 5.86%. The business’s quarterly revenue was down .1% on a year-over-year basis. During the same quarter last year, the company posted ($0.05) EPS. AngioDynamics updated its FY 2025 guidance to -0.380–0.340 EPS and its FY25 guidance to ($0.38)-($0.34) EPS.

AngioDynamics Trading Up 37.7 %

Shares of AngioDynamics stock opened at $12.94 on Thursday. The business has a fifty day simple moving average of $7.99 and a two-hundred day simple moving average of $7.34. The firm has a market capitalization of $525.80 million, a P/E ratio of -2.12 and a beta of 0.59. AngioDynamics has a 12 month low of $5.26 and a 12 month high of $13.13.

Analysts Set New Price Targets

ANGO has been the topic of several analyst reports. HC Wainwright reaffirmed a “buy” rating and issued a $14.00 target price on shares of AngioDynamics in a research note on Tuesday, December 10th. Canaccord Genuity Group lowered their price objective on shares of AngioDynamics from $13.00 to $12.00 and set a “buy” rating for the company in a research note on Friday, October 4th.

About AngioDynamics

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.